关注
Paul J Catalano
Paul J Catalano
Sr Lecturer on Biostatistics/Assoc Chair, Dept of Data Science Dana-Farber Cancer Institute
在 jimmy.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative …
BJ Giantonio, PJ Catalano, NJ Meropol, PJ O'Dwyer, EP Mitchell, ...
Journal of clinical oncology 25 (12), 1539-1544, 2007
28652007
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089
TE Le Voyer, ER Sigurdson, AL Hanlon, RJ Mayer, JS Macdonald, ...
Journal of clinical oncology 21 (15), 2912-2919, 2003
14372003
Patients' expectations about effects of chemotherapy for advanced cancer
JC Weeks, PJ Catalano, A Cronin, MD Finkelman, JW Mack, NL Keating, ...
New England Journal of Medicine 367 (17), 1616-1625, 2012
13232012
Molecular predictors of survival after adjuvant chemotherapy for colon cancer
T Watanabe, TT Wu, PJ Catalano, T Ueki, R Satriano, DG Haller, ...
New England Journal of Medicine 344 (16), 1196-1206, 2001
10972001
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group …
JD Berlin, P Catalano, JP Thomas, JW Kugler, DG Haller, AB Benson III
Journal of Clinical Oncology 20 (15), 3270-3275, 2002
9332002
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
DJ Sargent, HS Wieand, DG Haller, R Gray, JK Benedetti, M Buyse, ...
Journal of Clinical Oncology 23 (34), 8664-8670, 2005
7922005
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
DN Cagney, AM Martin, PJ Catalano, AJ Redig, NU Lin, EQ Lee, PY Wen, ...
Neuro-oncology 19 (11), 1511-1521, 2017
6562017
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
DA Braun, Y Hou, Z Bakouny, M Ficial, M Sant’Angelo, J Forman, ...
Nature medicine 26 (6), 909-918, 2020
6252020
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes
AC Berger, ER Sigurdson, T LeVoyer, A Hanlon, RJ Mayer, JS Macdonald, ...
Journal of clinical oncology 23 (34), 8706-8712, 2005
6252005
Using time-and size-resolved particulate data to quantify indoor penetration and deposition behavior
CM Long, HH Suh, PJ Catalano, P Koutrakis
Environmental science & technology 35 (10), 2089-2099, 2001
5672001
Relative contribution of outdoor and indoor particle sources to indoor concentrations
E Abt, HH Suh, P Catalano, P Koutrakis
Environmental science & technology 34 (17), 3579-3587, 2000
5372000
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with …
E Poplin, Y Feng, J Berlin, ML Rothenberg, H Hochster, E Mitchell, ...
Journal of clinical oncology 27 (23), 3778-3785, 2009
5282009
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089
DG Haller, PJ Catalano, JS Macdonald, MA O'Rourke, MS Frontiera, ...
Journal of Clinical Oncology 23 (34), 8671-8678, 2005
5062005
Impact of diabetes mellitus on outcomes in patients with colon cancer
JA Meyerhardt, PJ Catalano, DG Haller, RJ Mayer, JS Macdonald, ...
Journal of Clinical Oncology 21 (3), 433-440, 2003
5002003
Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern …
W Sun, S Lipsitz, P Catalano, JA Mailliard, DG Haller
Journal of Clinical Oncology 23 (22), 4897-4904, 2005
4292005
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG …
BJ Giantonio, PJ Catalano, NJ Meropol, PJ O’dwyer, EP Mitchell, ...
Journal of Clinical Oncology 23 (16_suppl), 2-2, 2005
4062005
Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology …
CR Nichols, PJ Catalano, ED Crawford, NJ Vogelzang, LH Einhorn, ...
Journal of Clinical Oncology 16 (4), 1287-1293, 1998
4061998
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins
MA Smith, L Rubinstein, JR Anderson, D Arthur, PJ Catalano, B Freidlin, ...
Journal of Clinical Oncology 17 (2), 569-569, 1999
3681999
Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma
JA Meyerhardt, PJ Catalano, DG Haller, RJ Mayer, AB Benson III, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
3622003
Mechanisms of morbidity and mortality from exposure to ambient air particles.
JJ Godleski, RL Verrier, P Koutrakis, P Catalano, B Coull, U Reinisch, ...
Research Report (Health Effects Institute), 5-88; discussion 89, 2000
3562000
系统目前无法执行此操作,请稍后再试。
文章 1–20